<DOC>
	<DOCNO>NCT01247467</DOCNO>
	<brief_summary>A number prognostic and/or predictive genomic signature breast cancer develop Genome Institute Singapore ( GIS ) . In past 1 year , GIS develop protocol method conduct expression assay formalin-fixed , paraffin-embedded ( FFPE ) tumor specimen . A study 800 tumor sample plan analyze gene signature compare conventional clinical prognosticator predictor . As investigator plan use archival tumor sample date back 1990s , aim pilot study first analyze 10 anonymized sample determine feasibility run assay old archival block . The information generate help u determine whether old sample ( diagnosed 2000 ) may select actual study .</brief_summary>
	<brief_title>Analysis Prognostic Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - Pilot Study</brief_title>
	<detailed_description>Up 10 archival breast tumor block obtain Department Pathology , NUH - half block patient diagnose year 2000 , half block patient diagnose year 2000-2005 ( control specimens ) . Basic tumor patient information collect without patient identifier - grade , stage , ER/PR/HER2 status , treatment receive , outcome data . 8-10 ten-micron section cut tumor block . RNA extract tumor section use Roche High Pure FFPE RNA Micro Kit . RNA profile use Illumina Veracode assay Affymetrix Quantigene assay . RNA extraction gene expression profile perform collabroators Genome Institute Singapore .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Half block breast cancer patient diagnose year 2000 . Half block breast cancer patient diagnose year 20002005 ( control specimens ) . Breast cancer patient diagnose year 2005 .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>